Navigation Links
Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference
Date:12/12/2007

PLYMOUTH MEETING, Pa., Dec. 12 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR) today announced that Jack Armstrong, President and Chief Executive Officer of Genaera, is scheduled to present at the 2007 RBC Capital Markets Healthcare Conference. The presentation is part of an RBC Capital Markets' panel discussion of diabetes and obesity, entitled, "The Pharmaceutical Sweet Spot: Diabetes & Obesity," and will take place in New York on Thursday, December 13 at 10:00 a.m. ET.

This panel presentation is being webcast at: http:/www.wsw.com/webcast/rbc84qpanel23

About Genaera

Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a first-in-class molecule, trodusquemine (MSI-1436), that has the potential to redefine the treatment paradigm for obesity and type 2 diabetes and is presently in a Phase 1 trial in obesity. In addition, Genaera has a value- driven, fully out-licensed partnership with MedImmune, Inc. for a second core program that is presently undergoing Phase 2 clinical testing in asthma. Genaera is committed to directing resources to its core program and the aggressive clinical development of its key assets to build stockholder value. For further information, please see our website at http://www.genaera.com.


'/>"/>
SOURCE Genaera Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Genaera Elects New Board Member and Announces Executive Appointments
2. Genaera to Present at Biotech 2007 and BIO InvestorForum
3. Genaera Corporation Announces Third Quarter Financial Results
4. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
5. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
6. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
7. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
8. BioElectronics Corporation Announces Singapore and Malaysia Sales
9. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
10. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
11. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... ... August 22, 2017 , ... ... and distribution of highly differentiated spinal implant technologies, announced today the appointment of ... years of spinal device industry experience to directing Cutting Edge Spine’s national sales ...
(Date:8/22/2017)... ... 2017 , ... KBioBox is pleased to announce the creation ... ananlysis. KBioBox has adapted their core technology and direct alignment algorithms to extend ... understand reports, extended indel analysis, and translocation analysis. , “The extended GUIDE-Seq analysis ...
(Date:8/21/2017)... ... August 21, 2017 , ... MacArthur ... of Hawaii, is pleased to announce the first Delos Wellness Signature™ residence in ... International Realty is working together with listing agent Kelly Allen, R(S) of Carvill ...
(Date:8/21/2017)... ... August 21, 2017 , ... Baltimore ... bio security firm, to bring its proprietary CANARY pathogen detection technology and high ... the Chinese firm has purchased an undisclosed number of PathSensors’ Zephyr pathogen detection ...
Breaking Biology Technology:
(Date:5/16/2017)... --  Bridge Patient Portal , an enterprise patient ... Systems , an electronic medical record solutions developer ... a partnership to build an interface between the ... products, including Centricity Practice Solution (CPS), Centricity Business ... integrations will allow healthcare delivery networks using GE ...
(Date:4/18/2017)... -- Socionext Inc., a global expert in SoC-based imaging and computing solutions, ... which features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ... will be showcased during the upcoming Medtec Japan at Tokyo Big ... Las Vegas Convention Center April 24-27. ... Click here for an image of ...
(Date:4/11/2017)... April 11, 2017 Crossmatch®, a globally-recognized ... solutions, today announced that it has been awarded ... Projects Activity (IARPA) to develop next-generation Presentation Attack ... "Innovation has been a driving force within ... will allow us to innovate and develop new ...
Breaking Biology News(10 mins):